Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Instil Bio Q2 Adj. EPS $(2.88) Misses $(2.50) Estimate, Cash, Cash Equivalents, Restricted Cash, Marketable Securities And Long-term Investments Of $103.6M Will Enable The Company To Fund Its Operating Plan Beyond 2026

Author: Benzinga Newsdesk | August 13, 2025 05:15am

Posted In: TIL

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist